Unlock 20% Off Global Market Reports Using Code ONLINE20 – Stay Informed on Trade Policies, Market Growth, and Key Disruptors
What Is the Projected Growth Rate of the Bone Metabolism Tests Market Through 2029?
The bone metabolism tests market size has grown strongly in recent years. It will grow from $1.90 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing osteoporosis diagnosis rates, rising awareness about bone-related disorders, a growing number of postmenopausal women, expanding use of DEXA scans, and an increasing aging population.
The bone metabolism tests market size is expected to see strong growth in the next few years. It will grow to $2.80 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to the growing need for early detection of bone disorders, increasing adoption of personalized treatment plans, rising focus on preventive healthcare, expansion of home-based diagnostic testing, and increasing availability of reimbursement for diagnostic tests. Major trends in the forecast period include technological advancements in imaging modalities, innovation in molecular testing methods, rising investment in research and development, development of AI-powered diagnostic platforms, and advancement in point-of-care bone testing tools.
Claim your free report sample now:
Which Drivers Are Positively Impacting the Bone Metabolism Tests Market?
The growing prevalence of osteoporosis and osteopenia is expected to propel the growth of the bone metabolism tests market going forward. Osteoporosis and osteopenia are musculoskeletal disorders characterized by low bone density and deterioration of bone tissue, leading to increased fragility and fracture risk, particularly in older adults. The prevalence of osteoporosis and osteopenia is increasing as aging populations experience accelerated bone loss, leading to reduced bone density. Bone metabolism tests aid in identifying and tracking osteoporosis and osteopenia by evaluating bone formation and breakdown markers. They offer valuable insight into bone turnover, supporting early intervention and treatment planning. For instance, in June 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government statutory agency, osteoporosis was responsible for 2,659 deaths, equating to 10.2 deaths per 100,000 population in 2022 and accounting for 1.4% of all deaths. Therefore, the growing prevalence of osteoporosis and osteopenia is driving the growth of the bone metabolism tests market.
Which Are the Leading Segments in the Bone Metabolism Tests Market by Revenue?
The bone metabolism tests market covered in this report is segmented
1) By Test Type: Biochemical Tests, Imaging Tests, Bone Density Tests, Histomorphometry, Molecular Testing
2) By Product: Assay Or Consumables, Instruments
3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Other Technologies
4) By Application: Osteoporosis Diagnosis, Bone Disease Diagnosis, Fracture Risk Assessment, Drug Development, Clinical Research
5) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings, Academic Institutions
Subsegments:
1) By Biochemical Tests: Serum Calcium Test, Serum Phosphorus Test, Alkaline Phosphatase Test, Parathyroid Hormone Test, Vitamin D Test
2) By Imaging Tests: X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Dual-Energy X-Ray Absorptiometry (DEXA), Positron Emission Tomography (PET)
3) By Bone Density Tests: Central Dual-Energy X-Ray Absorptiometry (DEXA), Peripheral Dual-Energy X-Ray Absorptiometry (DEXA), Quantitative Ultrasound, Quantitative Computed Tomography (CT), Single Photon Absorptiometry (SPA)
4) By Histomorphometry: Static Histomorphometry, Dynamic Histomorphometry, Bone Biopsy Analysis, Fluorochrome Labeling, Trabecular Thickness Measurement
5) By Molecular Testing: Gene Expression Profiling, Micro Ribonucleic Acid (MicroRNA) Analysis, Deoxyribonucleic Acid (DNA) Methylation Assay, Bone Turnover Marker Panels, Genetic Mutation Screening
Which Emerging Trends Are Driving the Bone Metabolism Tests Market?
Major companies operating in the bone metabolism tests market are focusing on developing advanced products such as blood-based diagnostic tools to enable earlier, less invasive, and more accurate detection of bone disorders. Blood-based diagnostic tools use blood samples to identify biomarkers linked to various health conditions. For bone health, they help detect changes in bone formation and breakdown, allowing early and non-invasive diagnosis of bone issues. For instance, in September 2022, University Hospitals of Geneva, a Switzerland-based university hospital, and the University of Geneva, a Switzerland-based public university, launched a new device for diagnosing bone fragility that was approved for marketing in the European Economic Area and Switzerland, receiving the CE mark. This device assesses bone quality through a blood test measuring periostin (k-POSTN), a protein related to bone strength, providing a more specific diagnosis than current imaging techniques like bone densitometry. It helps identify individuals at risk of osteoporotic fractures, including those with type 2 diabetes, enabling early therapeutic intervention to improve patient outcomes.
Who Are the Top Companies Contributing to the Bone Metabolism Tests Market Expansion?
Major companies operating in the bone metabolism tests market are F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings (LabCorp), Hologic Inc., bioMérieux SA, QuidelOrtho Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Takara Bio Inc., Randox Laboratories Ltd., Trivitron Healthcare Pvt. Ltd., MESO SCALE DIAGNOSTICS LLC, Immunodiagnostic Systems plc, DMS Imaging SA, Creative Diagnostics, Oxford Biosystems Ltd., Epitope Diagnostics Inc., Maccura Biotechnology Co. Ltd.
Get the full bone metabolism tests market report here:
How Are Market Trends Differentiating Across Key Regions in the Bone Metabolism Tests Market?
North America was the largest region in the bone metabolism tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone metabolism tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment